m.cabrera
Submits third-party assay reports on material purchased directly. Based in Zadar.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.49%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041626 | Selank | FGP | FGP-2511-D8133 | PeptideMeter | 2026-Q1 | 99.59 | 6.12 | 95.2 | Buyer-sourced | 0 | PASS |
| AX-2026-041449 | Humanin (HNG) | QYB | QYB-2512-A4980 | Janoshik | 2026-Q1 | 99.13 | 4.40 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041572 | Semaglutide | QSC | QSC-2602-G7336 | VendorInvestigate | 2026-Q1 | 97.79 | 4.95 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021186 | BPC-157 | PPG | PPG-2511-A6658 | Janoshik | 2025-Q4 | 99.93 | 2.15 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019257 | GHRP-6 | AMB | AMB-2508-T5301 | Kestrel | 2025-Q3 | 99.87 | 5.81 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018993 | Tirzepatide | ASY | ASY-{CAT}-1938 | Janoshik | 2025-Q3 | 99.49 | 4.55 | 98.3 | Buyer-sourced | 0 | PASS |
| AX-2025-018776 | GHRP-6 | FGP | FGP-2411-J8288 | PeptideMeter | 2025-Q2 | 99.93 | 5.37 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005146 | Liraglutide | SGN | SGN-2408-X9083 | Nordanalyt | 2024-Q4 | 98.28 | 2.97 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004385 | Retatrutide | TFS | TFS-{CAT}-9522 | Janoshik | 2024-Q1 | 98.81 | 4.18 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004737 | TB-500 | Homopeptide | HOMO-2308-R3867 | PeptideMeter | 2024-Q1 | 99.49 | 3.86 | 101.5 | Buyer-sourced | 0 | PASS |